Oligodendroglioma - 26 Studies Found
| Completed |
: Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma :
: 2006-08-08 : Drug: Temozolomide p.o.(by mouth), 150 mg/m2/d x days 1-7 |
| Completed |
: Temozolomide in Treating Patients With Anaplastic Oligodendroglioma : Brain and Central Nervous System Tumors : 1999-11-01 : Drug: temozolomide |
| Active, not recruiting |
: Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma :
: 2006-11-16 : Drug: temozolomide Schedule of Temozolomide administration: Temozolomide, 150 mg/m2/d x days 1-7 and 15- |
| Completed |
: Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma : Brain and Central Nervous System Tumors : 1999-11-01 :
|
| Completed |
: Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma : Brain and Central Nervous System Tumors : 1999-11-01 :
|
| Active, not recruiting |
: Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma :
: 2007-12-22 : Drug: temozolomide followed by high dose busulfan and thiotepa Temozolomide 200mg/m2 PO Days 1-5 recycle |
| No longer available |
: Expanded Access to ANG1005 for Individual Patients :
: Drug: ANG1005 |
| Recruiting |
: Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors :
: |
| Completed |
: Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma : Brain and Central Nervous System Tumors : 1999-11-01 :
|
| Completed |
: Topotecan in Treating Patients With Recurrent Brain Tumors : Brain and Central Nervous System Tumors : 1999-11-01 : Drug: topotecan hydrochloride |